The obesogenic effects of polyunsaturated fatty acids are dependent ...

More documents

Recommendations

Info

Cyclooxygenases and UCP1 PLoS ONE | www.plosone.org 8 June 2010 | Volume 5 | Issue 6 | e11391
Cyclooxygenases and UCP1 Figure 6. UCP1 expression is attenuated by an EP 4 receptor antagonist in Rb 2/2 adipocytes and induced by the EP4 receptor agonist 16,16dmPGE 2 in vivo. A.Expressions of EP 1 ,EP 2 ,EP 3 ,EP 4 and FP receptors were measured by RT-qPCR in iBAT and iWAT isolated from warm- and cold-acclimated mice, and in Rb 2/2 adipocytes treated with vehicle or isoproterenol (100 nM) and 9-cis-retinoic acid (1 mM). B. Rb 2/2 adipocytes were treated with vehicle or isoproterenol (100 nM) and 9-cis-retinoic acid (1 mM) by RT-qPCR in absence and presence of AL8810, AH6809, or AH23848, which are FP, EP 1 /EP 2 and EP 4 receptor antagonists, respectively. Expressions of genes were measured by RT-qPCR. The bars represent mean 6 standard error. Different letters indicate statistically significant differences (p,0.05). C. C57BL/6J mice were subcutaneously injected with vehicle or 16,16dmPGE 2 (50 mM/kg) every 12 h for 48 h. Expressions of genes were measured by RT-qPCR. The bars represent mean 6 standard error (n = 5). * indicates statistical significant difference between vehicle and 16,16 dmPGE 2 treated mice (p,0.05). doi:10.1371/journal.pone.0011391.g006 mice. Also, injection of a stable analog of the COX2 downstream product PGE 2 , 16,16-dimethyl-PGE 2 , induced UCP1 expression in iWAT. Forced expression of COX2, alone or in combination with COX1, induced UCP1 expression in a cell model resembling inguinal adipocytes. Finally, the inhibition of COX activity not only attenuated diet-induced UCP1 expression in iWAT, but also increased weight gain in Sv129 mice kept at thermoneutrality. The association between diet-induced thermogenesis and the recruitment of brown adipose tissue was first noted more than 30 years ago and believed to involve the classical brown adipose tissue located in the interscapular region [59]. The anti-obesity role of UCP1 was challenged by the finding that UCP1 KO mice were not obese [60]. However, the recent demonstration that UCP1 ablation per se induced obesity when the mice were kept at thermoneutrality [61] clearly indicates that UCP1 is important in diet-induced energy dissipation at thermoneutrality. Our data indicate that inhibition of COX activity increased weight gain and concomitantly attenuated diet-induced UCP1 expression in iWAT, but not iBAT in Sv129 mice kept at thermoneutrality, pointing to a novel role of COX activity in the control of energy balance and the development of obesity. These results are in line with our earlier observation that enhanced cAMP signaling in response to an increased glucagon/insulin ratio led to an increased COX-mediated PGE 2 production. This was accompanied by increased expression of UCP1 in iWAT, but not in iBAT, and decreased feed efficiency [62]. Although neither COX1 KO nor COX2 KO mice are obese, COX2 +/2 KO mice have more adipose tissue than wild-type littermates when fed an obesogenic diet [48]. The reason why COX2 +/2 , but not COX2 KO mice were reported to be prone to obesity is not clear. However, these studies were not performed at thermoneutrality [48]. A similar phenomenon is actually seen in GLUT4 KO mice, where the majority of GLUT4 2/+ , but not GLUT4 2/2 mice develops diabetes [63]. Moreover, release of PGE 2 from adipose tissue in COX2 +/2 mice was reported to be reduced compared to adipose tissue from wild-type mice [48] and adipose tissue cultures obtained from obese rats have lower PGE 2 release rates than cultures from lean rats [38]. In addition, microsomal prostaglandin α Figure 7. Indomethacin prevents high-fat diet-induced UCP1 expression in iWAT but not iBAT in the obesity-resistant Sv129 mouse strain. Mice were fed a very high-fat diet (VHF) with or without indomethacin supplementation (16 ppm) for 4 weeks at a temperature of 28–30uC. One group of mice was killed before the experiment started. A. Body weight gain and energy intake relative to body weight gain. B. Different adipose tissue depots were dissected and weighed. C and D. Representative paraffin-embedded representative sections from iWAT and iBAT were stained with hematoxylin and eosin. The scale bars represent 50 mM. E. Expressions of genes in iWAT and iBAT were measured by RT-qPCR. The bars represent mean 6 standard error (n = 6). * indicates statistical significant difference (p,0.05) between different groups. doi:10.1371/journal.pone.0011391.g007 PLoS ONE | www.plosone.org 9 June 2010 | Volume 5 | Issue 6 | e11391
Page 1 and 2:
The obesogenic effects of polyunsat
Page 3 and 4:
Table of Contents Acknowledgement .
Page 5 and 6:
Abstract in Danish Polyumættede n-
Page 7 and 8:
Polyunsaturated fatty acids in the
Page 9 and 10:
was more than 3 times higher in the
Page 11 and 12:
gluconeogenesis and ureagenesis (Fi
Page 13 and 14:
high dietary PUFAs, the modulation
Page 15 and 16:
In a pair of population studies, an
Page 17 and 18:
18. Massiera, F. et al. Arachidonic
Page 19 and 20:
54. Xu, J. et al. Polyunsaturated f
Page 21 and 22:
Annexes 1. Ma T, Liaset B, Hao Q, P
Page 23 and 24:
Fish Oil, Sucrose and Obesity Obesi
Page 25 and 26:
Fish Oil, Sucrose and Obesity Figur
Page 27 and 28:
Fish Oil, Sucrose and Obesity Table
Page 29 and 30: Fish Oil, Sucrose and Obesity Figur
Page 31 and 32: Fish Oil, Sucrose and Obesity Figur
Page 33 and 34: Fish Oil, Sucrose and Obesity 6. Ma
Page 35 and 36: Carbohydrate source and insulin sec
Page 37 and 38: 20 21 22 23 24 25 26 27 28 29 30 31
Page 39 and 40: 68 69 70 71 72 73 74 75 76 77 78 79
Page 41 and 42: 114 115 116 117 118 119 120 121 122
Page 43 and 44: 160 161 162 163 164 165 166 167 168
Page 45 and 46: 208 209 210 211 212 213 214 215 216
Page 47 and 48: 256 257 258 259 260 261 262 263 264
Page 49 and 50: 302 303 304 305 306 307 308 309 310
Page 51 and 52: 350 351 FIGURE LEGENDS 352 353 354
Page 53 and 54: 398 399 400 401 402 403 404 subunit
Page 55 and 56: 446 447 448 449 450 451 gamma, coac
Page 57 and 58: 484 485 486 TABLE 1. Macronutrient
Page 59 and 60: Energy (kJ/g) 17.16 25.12 25.12 25.
Page 61 and 62: 561 562 563 564 565 566 567 568 569
Page 63 and 64: 635 636 637 638 639 640 641 642 643
Page 65: 711 712 713 714 715 716 717 718 719
Page 74 and 75: Cyclooxygenases and UCP1 Although i
Page 76 and 77: Cyclooxygenases and UCP1 Figure 2.
Page 78 and 79: Cyclooxygenases and UCP1 Figure 4.
Page 82 and 83: Cyclooxygenases and UCP1 E synthase
Page 84 and 85: Cyclooxygenases and UCP1 29. Granne
Page 86 and 87: JBC Papers in Press. Published on J
Page 88 and 89: hydrolysate (SPH), would be protect
Page 90 and 91: was used as the liver cytosolic fra
Page 92 and 93: In order to demonstrate that bile a
Page 94 and 95: Nutritional regulation of endogenou
Page 96 and 97: in increased whole body energy expe
Page 98 and 99: 38. Kanehisa M, and Goto S. (2000)
Page 100 and 101: FOOTNOTES This work was carried out
Page 102 and 103: fed the same diets, plus the SPH-di
Page 104 and 105: Figure 2 A nmol/ min/ mg prot 2,4 1
Page 106 and 107: Figure 4 A 6 Liver Pparα B 21 Live
Page 108 and 109: Figure 7 A Plasma ALAT B Liver Ucp2
Page 110 and 111: Ruzzin et al. investigated the meta
Page 112 and 113: Ruzzin et al. CD14, and rho kinases
Page 114 and 115: Ruzzin et al. salmon oil induced a
show all

The obesogenic effects of polyunsaturated fatty acids are dependent ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?